Skip to main content

Advertisement

Log in

Insulin growth factor-1 pathway in cervical carcinoma cancer stem cells

  • Published:
Molecular and Cellular Biochemistry Aims and scope Submit manuscript

Abstract

Cancer stem cells (CSC) drive tumour progression and are implicated in relapse and resistance to conventional cancer therapies. Identification of differentially expressed genes by gene expression (GEP) profiling may help identify the differentially activated signalling pathways in cancer stem cells as opposed to bulk tumour cells which will provide new insights into cancer stem cell biology and aid in identification of novel therapeutic targets. Our study focused on the inhibition of CSC from cervical cancer cell lines by targeting insulin-like growth factor (IGF), which was identified by differential GEP. Targeted inhibition of IGF-1 by JB-1 trifluoroacetate (inhibitor of IGF) was carried out in SiHa, RSBS-14 and RSBS-43 cervical cancer derived cell lines. Effect of cisplatin was also evaluated. Inhibition of IGF-1 signalling was confirmed by demonstration of reduction in p-Akt levels. The cell biological effects of IGF-1 inhibition included an increase in G2M/S fraction, increased apoptosis and decreased invasive ability. JB-1 and cisplatin showed synergism. However, transcript levels of stemness and EMT markers showed variable levels following IGF inhibition. Overall, this proof-of-concept study has shown that IGF-1 is an attractive target for inhibition of CSC in invasive cervical cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

Data Availability

The link for public data https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE120270

References

  1. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M et al (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136:E359–E386

    Article  CAS  PubMed  Google Scholar 

  2. Dean M, Fojo T, Bates S (2005) Tumour stem cells and drug resistance. Nat Rev Cancer 5:275–284

    Article  CAS  PubMed  Google Scholar 

  3. Shim C, Zhang W, Rhee CH, Lee JH (1998) Profiling of differentially expressed genes in human primary cervical cancer by complementary DNA expression array. Clin Cancer Res 4:3045–3050

    CAS  PubMed  Google Scholar 

  4. Cheng Q, Lau WM, Tay SK, Chew SH, Ho TH, Hui KM (2002) Identification and characterization of genes involved in the carcinogenesis of human squamous cell cervical carcinoma. Int J Cancer 98:419–426

    Article  CAS  PubMed  Google Scholar 

  5. Wong YF, Selvanayagam ZE, Wei N et al (2003) Expression genomics of cervical cancer: molecular classification and prediction of radiotherapy response by DNA microarray. Clin Cancer Res 9:5486–5492

    CAS  PubMed  Google Scholar 

  6. Bachtiary B, Boutros PC, Pintilie M et al (2006) Gene expression profiling in cervical cancer: an exploration of intratumor heterogeneity. Clin Cancer Res 12:5632–5640

    Article  CAS  PubMed  Google Scholar 

  7. Javed S, Sharma BK, Sood S et al (2018) Significance of CD133 positive cells in four novel HPV-16 positive cervical cancer-derived cell lines and biopsies of invasive cervical cancer. BMC Cancer 18:357

    Article  PubMed  PubMed Central  Google Scholar 

  8. Sunters A, Armstrong VJ, Zaman G et al (2010) Mechano-transduction in osteoblastic cells involves strain-regulated estrogen receptor alpha-mediated control of insulin-like growth factor (IGF) I receptor sensitivity to Ambient IGF, leading to phosphatidylinositol 3-kinase/AKT-dependent Wnt/LRP5 receptor-independent activation of beta-catenin signaling. J Biol Chem 285:8743–8758

    Article  CAS  PubMed  Google Scholar 

  9. Lin M, Ye M, Zhou J et al (2019) Recent Advances on the Molecular Mechanism of Cervical Carcinogenesis Based on Systems Biology Technologies. Comput Struct Biotechnol J 17:241–250

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Rao Q-X, Yao T-T, Zhang B-Z et al (2012) Expression and Functional Role of ALDH1 in Cervical Carcinoma Cells. Asian Pac J Cancer Prev 13:1325–1331

    Article  PubMed  Google Scholar 

  11. Lopez J, Poitevin A, Mendoza-Martinez V, Perez-Plasencia C, Garcia-Carranca A (2012) Cancer-initiating cells derived from established cervical cell lines exhibit stem-cell markers and increased radioresistance. BMC Cancer 12:48

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Shen MR, Hsu YM, Hsu KF, Chen YF, Tang MJ, Chou CY (2006) Insulin-like growth factor 1 is a potent stimulator of cervical cancer cell invasiveness and proliferation that is modulated by alphavbeta3 integrin signaling. Carcinogenesis 27:962–971

    Article  CAS  PubMed  Google Scholar 

  13. Steller MA, Delgado CH, Bartels CJ, Woodworth CD, Zou Z (1996) Overexpression of the insulin-like growth factor-1 receptor and autocrine stimulation in human cervical cancer cells. Cancer Res 56:1761–1765

    CAS  PubMed  Google Scholar 

  14. Prager D, Li HL, Asa S, Melmed S (1994) Dominant negative inhibition of tumorigenesis in vivo by human insulin-like growth factor I receptor mutant. Proc Natl Acad Sci U S A 91:2181–2185

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Huang YF, Shen MR, Hsu KF, Cheng YM, Chou CY (2008) Clinical implications of insulin-like growth factor 1 system in early-stage cervical cancer. Br J Cancer 99:1096–1102

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Nakamura K, Hongo A, Kodama J, Miyagi Y, Yoshinouchi M, Kudo T (2000) Down-regulation of the insulin-like growth factor I receptor by antisense RNA can reverse the transformed phenotype of human cervical cancer cell lines. Cancer Res 60:760–765

    CAS  PubMed  Google Scholar 

  17. Somri-Gannam L, Meisel-Sharon S, Hantisteanu S, et al. IGF1R Axis Inhibition Restores Dendritic Cell Antitumor Response in Ovarian Cancer. Transl Oncol. 2020; 100790.

  18. Chen J, Zeng J, Xin M, Huang W, Chen X (2011) Formononetin induces cell cycle arrest of human breast cancer cells via IGF1/PI3K/Akt pathways in vitro and in vivo. Horm Metab Res 43:681–686

    Article  CAS  PubMed  Google Scholar 

  19. Singh B, Smith JA, Axelrod DM et al (2014) Insulin-like growth factor-I inhibition with pasireotide decreases cell proliferation and increases apoptosis in pre-malignant lesions of the breast: a phase 1 proof of principle trial. Breast Cancer Res 16:463

    Article  PubMed  PubMed Central  Google Scholar 

  20. Shukla S, Maclennan GT, Hartman DJ, Fu P, Resnick MI, Gupta S (2007) Activation of PI3K-Akt signaling pathway promotes prostate cancer cell invasion. Int J Cancer 121:1424–1432

    Article  CAS  PubMed  Google Scholar 

  21. Zhou P, Li B, Liu F et al (2017) The epithelial to mesenchymal transition (EMT) and cancer stem cells: implication for treatment resistance in pancreatic cancer. Mol Cancer 16:52

    Article  PubMed  PubMed Central  Google Scholar 

  22. Sharma A, De R, Javed S, Srinivasan R, Pal A, Bhattacharyya S. Sonic hedgehog pathway activation regulates cervical cancer stem cell characteristics during epithelial to mesenchymal transition. J Cell Physiol. 2019;4.

  23. Denduluri SK, Idowu O, Wang Z et al (2015) Insulin-like growth factor (IGF) signaling in tumorigenesis and the development of cancer drug resistance. Genes Dis 2:13–25

    Article  CAS  PubMed  Google Scholar 

  24. King H, Aleksic T, Haluska P, Macaulay VM (2014) Can we unlock the potential of IGF-1R inhibition in cancer therapy? Cancer Treat Rev 40:1096–1105

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Funding

Department of Science and Technology, Govt. of India, grant reference no.- DST No: D.O. No.-SR/SO/HS-0166/2010; PGI Intramural Research Scheme No. 71/5-EDU/12/1363; Shifa Javed was supported by Indian Council of Medical Research Junior Research Fellowships ICMR-JRF-2012/HRD-139(10056).

Author information

Authors and Affiliations

Authors

Contributions

SJ conducted all experiments and manuscript writing; SB, RB and RS conceived the project, designed the study. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Radhika Srinivasan.

Ethics declarations

Conflict of interest

The authors listed have no conflicts of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary file1 (JPG 147 kb)

Supplementary file2 (XLSX 64 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Javed, S., Bhattacharyya, S., Bagga, R. et al. Insulin growth factor-1 pathway in cervical carcinoma cancer stem cells. Mol Cell Biochem 473, 51–62 (2020). https://doi.org/10.1007/s11010-020-03807-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11010-020-03807-6

Keywords

Navigation